Physician profile
Ashok Agarwal
NPI 1003839838
$745.76
in general payments reported to CMS, 2019-2025
13 companies · $207 in 2025
The $207 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2020: $130 · 2022: $94.43 · 2023: $70.19 · 2024: $88.32 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $365.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $180.48 | 2019-2025 | Aveir |
| Edwards Lifesciences Corporation | $155.47 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| E.R. Squibb & Sons, L.L.C. | $120.30 | 2024-2025 | Eliquis, Camzyos |
| Novo Nordisk INC | $56.98 | 2022 | |
| Cardiva Medical, INC. | $56.44 | 2025 | Optowire |
| Janssen Pharmaceuticals, INC | $51.10 | 2020-2023 | Xarelto |
| Boston Scientific Corporation | $23.85 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $20.93 | 2024 | Arcalyst |
| Pfizer INC. | $18.25 | 2023 | |
| Merck Sharp & Dohme LLC | $17.84 | 2023 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.18 | 2022 | |
| Baxter Healthcare | $15.12 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Astrazeneca Pharmaceuticals LP | $12.82 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashok Agarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.